Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oric Pharmaceuticals | ORIC | Oct 30, 2024 | 9.42 | +4.67 |
Oriental Culture | OCG | Oct 30, 2024 | 1.37 | +2.63 |
Oriental Rise Holdings | ORIS | Oct 30, 2024 | 8.27 | 0.00 |
Origin Agritech | SEED | Oct 30, 2024 | 2.60 | 0.00 |
Origin Bancorp | OBK | Oct 30, 2024 | 32.22 | +2.22 |
Origin Materials A | ORGN | Oct 30, 2024 | 1.39 | +0.72 |
Orion Energy Systems | OESX | Oct 30, 2024 | 0.96 | -1.01 |
Orion Group | ORN | Oct 30, 2024 | 5.42 | +1.31 |
Orion Office REIT | ONL | Oct 30, 2024 | 3.84 | -0.78 |
Orion S.A. | OEC | Oct 30, 2024 | 15.27 | +1.87 |
Orix ADR | IX | Oct 30, 2024 | 106.46 | -0.34 |
Orla Mining | ORLA | Oct 30, 2024 | 4.84 | -2.42 |
Ormat Technologies | ORA | Oct 30, 2024 | 80.15 | -1.04 |
Orrstown Financial Services | ORRF | Oct 30, 2024 | 37.84 | +0.13 |
Orthofix Medical | OFIX | Oct 30, 2024 | 16.35 | -0.06 |
OrthoPediatrics | KIDS | Oct 30, 2024 | 27.00 | +1.54 |
Oruka Therapeutics | ORKA | Oct 30, 2024 | 28.88 | 0.00 |
OS Therapies | OSTX | Oct 30, 2024 | 2.71 | 0.00 |
Oscar Health A | OSCR | Oct 30, 2024 | 17.04 | +6.97 |
Oshkosh | OSK | Oct 30, 2024 | 106.46 | -1.27 |
OSI Systems | OSIS | Oct 30, 2024 | 135.97 | +1.80 |
Osisko Development | ODV | Oct 30, 2024 | 1.81 | -2.69 |
Osisko Gold Royalties | OR | Oct 30, 2024 | 21.03 | +0.10 |
Ostin Technology Group | OST | Oct 30, 2024 | 0.43 | +38.58 |
Otis Worldwide | OTIS | Oct 30, 2024 | 98.28 | -3.05 |
Otter Tail | OTTR | Oct 30, 2024 | 79.04 | -0.35 |
Ouster | OUST | Oct 30, 2024 | 6.97 | -1.83 |
Outbrain | OB | Oct 30, 2024 | 4.37 | +1.16 |
Outfront Media | OUT | Oct 30, 2024 | 18.25 | -2.14 |
Outlook Therapeutics | OTLK | Oct 30, 2024 | 5.77 | +0.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.